The role of a gram-positive microflora and its resistance in purulent-necrotic complications in patients, suffering syndrome of diabetic foot
Abstract
Objective. To improve the results of treatment in patients, suffering diabetic foot syndrome (DFS), using conduction of the directed antibacterial therapy, taking into account the resistance of microflora revealed, and to reveal the role of a gram-positive microflora in occurrence of complications.
Materials and methods. There were examined 1824 patients, suffering DFS for period from 2015 to 2019 yr., who suffered purulent-necrotic affections of the foot - abscess, phlegmon, purulent tendovaginitis, purulent arthritis, gangrene. All the patients suffered diabetes mellitus Type 2, average duration of which have constituted (12.3 ± 2.7) yrs. Qualitative content of microflora and sensitivity of cultures for antibiotics were revealed on automatic microbiological analizators «Vitek2» and BacT/ALERT (France).
Results. The cause of purulent-necrotic complications was a gram-positive microflora, which in 57.1 - 66.8% patients was diagnosed in monoinfection and prevailed in a content of microbial associations. Phenomena of resistance to the main antibacterial preparations was revealed in 37.4% bacteria. The biggest resistance have had Staphylococcus aureus and Enterococcus faecalis. In 62.5% patients, owing Staphylococcus aureus, a resistance gene to Staphylococcus aureus with three genetic variations were revealed, which differed in accordance to resistance for certain groups of antibiotics. The most significant MRSA Type 3 - panresistant (in 6/2% patients).
Conclusion. Investigations of purulent-necrotic foci in patients with the DFS witnesses, that the leading microorganism while development of complications constitutes a gram-positive microflora, which is characterized by presence of polyresistant and panresistant strains. Such a condition gives background to necessity for correcting of the antibacterial therapy administered.
References
Salmanov AG, Usenko AYu. Antibiotikorezistentnost nozokomialnyh shtammov Staphylococcus aureus v hirugicheskih stacionarah Ukrainy: rezultaty mnogocentrovogo issledovanija (2015-2016 gg.) Klin khir. 2018;85(5): 5-9. doi: 10.26779/2522-1396.2018.05.05/. [In Russian].
Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K, International working group on the diabetic foot (IWGDF). Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents. 2016;32 Suppl 1:7-15. doi: 10.1002/dmrr.2695.
Sokolova VI, Sychev DA, Babarina MB. Diabeticheskaja stopa: vozmozhnosti antibakterialnoj i antioksidantnoj terapii. Antibiotiki i himioterapija. 2018;(5):10-5. [In Russian].
Pikuza AV, Rashitov LF, Mitronin MI. Sovremennye podhody v lechenii pacientov s sindromom diabeticheskoj stopy. Lechashhiy vrach. 2018;(6):78-9. [In Russian].
Crouzet J, Lavigne JP, Richard JL, Sotto A. Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy. Int J Infect Dis. 2011 15(9):e601-10. doi: 10.1016/j.ijid.2011.05.003.
Gotz J, Lange M, Dullien S, Grifka J, Hertel G, Baier C, Koeck F. Off-loading strategies in diabetic foot syndrome-evaluation of different devices. Int Orthop. 2017;41(2): 239-46. doi: 10.1007/s00264-016-3358-1.
Mynakov OE, Andreev AA, Ostroushko AP. Sindrom diabeticheskoi stopy. Vestnik jeksperemental.noj i klinicheskij hirurgii. 2017;10 (2):165-72. doi: 10.18499/2070-478X-2017-10-2-165-172. [In Russian].
Peters1 EJ, Lipsky BA, Aragon-Sanchez J. Interventions in the management of infection in the foot in diabetes: a systematic. Diabetes Metab Res Rev. 2016;32 Suppl 1:145 - 53. doi: 10.1002/dmrr.2706.
Rundo AI. Sovremennye aspekty etiologii i patogeneza diabeticheskoj stopy. Novosti khirurgii. 2015;23(1):97−103. doi: 10.18484/2305-0047.2015.1.97. [In Russian].
Nigam Y. Knight J. Diabetes management 3: the pathogenesis and management of diabetic foot ulcers. Nursing Times. 2017;113(5): 51-4.
Ahmad J. The diabetic foot. Diabetes Metab. Syndr. 2016;10(1):48-60. doi: 10.1016/j.dsx.2015.04.002.
Trybushnoi OV, Shapoval SD, Savon IL, Slobodchenko LIu. Mikrobnyi peizazh hniinykh oseredkiv u khvorykh z uskladnenym syndromom diabetychnoi stopy ta pry rozvytku sepsysu. Ukrainskyi zhurnal khirurhii. 2017;(1): 35-9. [In Ukrainian].
Elraiyah T, Prutsky G, Domecq JP, Tsapas A, Nabhan M, Frykberg RG, et al. A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers. J Vasc Surg. 2016;63(2): 59-68. doi: 10.1016/j.jvs.2015.10.006.
Herasymchuk PO, Shidlovskyi VO, Fira DB. Varianty perebihu ranovoho protsesu u khvorykh iz syndromom diabetychnoi stopy. Suchasni medychni tekhnolohii. 2019;(1): 40-4. [In Ukrainian].
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18-55. doi: 10.1093/cid/ciq146.
Vatankhah N, Jahangiri Y, Landry GJ, Moneta GL, Azarbal AF. Effect of systemic insulin treatment on diabetic wound healing Wound Repair Regen. 2017;25(2). 288-91. doi: 10.1111/wrr.12514.
This work is licensed under a Creative Commons Attribution 4.0 International License.